Literature DB >> 22185833

Emergence and reemergence of smallpox: the need for development of a new generation smallpox vaccine.

Sergei N Shchelkunov1.   

Abstract

The review summarizes the archive data on smallpox, history of ancient civilizations, and the most recent data on the genome organization of orthopoxviruses, their evolutionary relationships, and the time points of smallpox emergence. The performed analysis provides the grounds for the hypothesis that smallpox could have emerged several times as a result of evolutionary changes in the zoonotic ancestor virus and disappeared due to insufficient population size of ancient civilizations. Smallpox reemerged in the Indian subcontinent approximately 2500-3000 years before present, which resulted in endemization of this anthroponotic infection, which had been preserved until the smallpox eradication in the 20th century AD. The conclusion suggests a potential possibility of future variola virus reemergence, presenting a great menace for mankind, as well as the need for development of new safe smallpox vaccines, design of anti-smallpox drugs, and activation of the control of zoonotic human orthopoxvirus infections.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22185833     DOI: 10.1016/j.vaccine.2011.05.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine.

Authors:  Jesse D Troy; Heather R Hill; Marian G Ewell; Sharon E Frey
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

2.  Generation of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genes.

Authors:  Zhiyong Xu; Dimitrios Zikos; Nikolaus Osterrieder; B Karsten Tischer
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

3.  The Vaccinia Virus H3 Envelope Protein, a Major Target of Neutralizing Antibodies, Exhibits a Glycosyltransferase Fold and Binds UDP-Glucose.

Authors:  Kavita Singh; Apostolos G Gittis; Rossitza K Gitti; Stanley A Ostazeski; Hua-Poo Su; David N Garboczi
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

4.  Orthopoxvirus genes that mediate disease virulence and host tropism.

Authors:  Sergei N Shchelkunov
Journal:  Adv Virol       Date:  2012-07-30

5.  Highly immunogenic variant of attenuated vaccinia virus.

Authors:  S N Yakubitskyi; I V Kolosova; R A Maksyutov; S N Shchelkunov
Journal:  Dokl Biochem Biophys       Date:  2016-03-31       Impact factor: 0.834

6.  An increasing danger of zoonotic orthopoxvirus infections.

Authors:  Sergei N Shchelkunov
Journal:  PLoS Pathog       Date:  2013-12-05       Impact factor: 6.823

7.  Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses.

Authors:  Sharon E Frey; Jack T Stapleton; Zuhair K Ballas; Wendy L Rasmussen; Thomas M Kaufman; Tammy P Blevins; Travis L Jensen; D Huw Davies; Magdalena Tary-Lehmann; Paul Chaplin; Heather Hill; Johannes B Goll
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 7.759

8.  Prediction of steps in the evolution of variola virus host range.

Authors:  Chad Smithson; Alex Purdy; Adrian J Verster; Chris Upton
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

9.  Attenuation of Vaccinia Virus.

Authors:  S N Yakubitskiy; I V Kolosova; R A Maksyutov; S N Shchelkunov
Journal:  Acta Naturae       Date:  2015 Oct-Dec       Impact factor: 1.845

Review 10.  Defending against smallpox: a focus on vaccines.

Authors:  Emily A Voigt; Richard B Kennedy; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2016-04-28       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.